title: Transient weakness and compound muscle action potential decrement in myotonia congenita.
abstract: Twenty-five Turkish patients with recessive myotonia congenita (RMC), 16 of whom had genetic confirmation, were studied. Nineteen had transient weakness. In the upper extremities, onset age of transient weakness was usually in the early teens. All untreated RMC patients had a compound muscle action potential decrement of > or =25%, usually above 50%, with repetitive nerve stimulation at 10/s for 5 s. Patients with other nondystrophic diseases with myotonia, except 1 patient with dominant myotonia congenita, had no transient weakness and a CMAP decrement below 25%.
authors.affiliation: Department of Neurology, Istanbul Faculty of Medicine, University of Istanbul, Turkey.
authors.forename: F
authors.initials: F
authors.lastname: Deymeer
authors.forename: S
authors.initials: S
authors.lastname: Cakirkaya
authors.forename: P
authors.initials: P
authors.lastname: Serdaroğlu
authors.forename: L
authors.initials: L
authors.lastname: Schleithoff
authors.forename: F
authors.initials: F
authors.lastname: Lehmann-Horn
authors.forename: R
authors.initials: R
authors.lastname: Rüdel
authors.forename: C
authors.initials: C
authors.lastname: Ozdemir
mesh_terms: D000200:Action Potentials / Q000502:physiology; D000293:Adolescent; D000328:Adult; D001132:Arm; D002648:Child; D004558:Electric Stimulation; D005260:Female; D005808:Genes, Recessive; D006801:Humans; D008297:Male; D009119:Muscle Contraction / Q000502:physiology; D018908:Muscle Weakness / Q000150:complications* / Q000503:physiopathology*; D018482:Muscle, Skeletal / Q000503:physiopathology*; D009224:Myotonia Congenita / Q000150:complications* / Q000235:genetics / Q000503:physiopathology*; D013997:Time Factors